Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing

NCT04798768 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04798768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 20, 2021
Completion date
December 31, 2030
Enrollment
297 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, ventricular, tachycardia, ventricular